Home > > Europe And Global Point of Care Molecular Diagnostics Market- Size, Share, Growth Rate, and Forecast
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET 3.1. OVERVIEW 3.2. EUROPE 3.2.1. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.2. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.3. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY 3.2.4.1. GERMANY 3.2.4.1.1. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.1.2. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.1.3. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.2. FRANCE 3.2.4.2.1. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.2.2. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.2.3. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.3. UK 3.2.4.3.1. UK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.3.2. UK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.3.3. UK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.4. ITALY 3.2.4.4.1. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.4.2. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.4.3. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.5. SPAIN 3.2.4.5.1. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.5.2. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.5.3. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.6. REST OF EUROPE 3.2.4.6.1. REST OF EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.6.2. REST OF EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.6.3. REST OF EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY CHAPTER 4: GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 4.1. OVERVIEW 4.2. INFECTIOUS DISEASE 4.2.1. INFECTIOUS DISEASE MARKET, BY REGION 4.2.1.1. NORTH AMERICA INFECTIOUS DISEASE MARKET, BY COUNTRY 4.2.1.2. EUROPE INFECTIOUS DISEASE MARKET, BY COUNTRY 4.2.1.3. ASIA INFECTIOUS DISEASE MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA INFECTIOUS DISEASE MARKET, BY COUNTRY 4.3. ONCOLOGY 4.3.1. ONCOLOGY MARKET, BY REGION 4.3.1.1. NORTH AMERICA ONCOLOGY MARKET, BY COUNTRY 4.3.1.2. EUROPE ONCOLOGY MARKET, BY COUNTRY 4.3.1.3. ASIA ONCOLOGY MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA ONCOLOGY MARKET, BY COUNTRY 4.4. HEMATOLOGY 4.4.1. HEMATOLOGY MARKET, BY REGION 4.4.1.1. NORTH AMERICA HEMATOLOGY MARKET, BY COUNTRY 4.4.1.2. EUROPE HEMATOLOGY MARKET, BY COUNTRY 4.4.1.3. ASIA HEMATOLOGY MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA HEMATOLOGY MARKET, BY COUNTRY 4.5. OTHER APPLICATIONS 4.5.1. OTHER APPLICATIONS MARKET, BY REGION 4.5.1.1. NORTH AMERICA OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.2. EUROPE OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.3. ASIA OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA OTHER APPLICATIONS MARKET, BY COUNTRY CHAPTER 5: GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 5.1. OVERVIEW 5.2. HOSPITALS 5.2.1. HOSPITALS MARKET, BY REGION 5.2.1.1. NORTH AMERICA HOSPITALS MARKET, BY COUNTRY 5.2.1.2. EUROPE HOSPITALS MARKET, BY COUNTRY 5.2.1.3. ASIA HOSPITALS MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA HOSPITALS MARKET, BY COUNTRY 5.3. CLINICS 5.3.1. CLINICS MARKET, BY REGION 5.3.1.1. NORTH AMERICA CLINICS MARKET, BY COUNTRY 5.3.1.2. EUROPE CLINICS MARKET, BY COUNTRY 5.3.1.3. ASIA CLINICS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA CLINICS MARKET, BY COUNTRY 5.4. OTHER END USERS 5.4.1. OTHER END USERS MARKET, BY REGION 5.4.1.1. NORTH AMERICA OTHER END USERS MARKET, BY COUNTRY 5.4.1.2. EUROPE OTHER END USERS MARKET, BY COUNTRY 5.4.1.3. ASIA OTHER END USERS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA OTHER END USERS MARKET, BY COUNTRY CHAPTER 6: GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 6.1. OVERVIEW 6.2. PCR 6.2.1. PCR MARKET, BY REGION 6.2.1.1. NORTH AMERICA PCR MARKET, BY COUNTRY 6.2.1.2. EUROPE PCR MARKET, BY COUNTRY 6.2.1.3. ASIA PCR MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA PCR MARKET, BY COUNTRY 6.3. IN SITU HYBRIDIZATION 6.3.1. IN SITU HYBRIDIZATION MARKET, BY REGION 6.3.1.1. NORTH AMERICA IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.3.1.2. EUROPE IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.3.1.3. ASIA IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.4. SEQUENCING 6.4.1. SEQUENCING MARKET, BY REGION 6.4.1.1. NORTH AMERICA SEQUENCING MARKET, BY COUNTRY 6.4.1.2. EUROPE SEQUENCING MARKET, BY COUNTRY 6.4.1.3. ASIA SEQUENCING MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA SEQUENCING MARKET, BY COUNTRY 6.5. ISOTHERMAL AMPLIFICATION 6.5.1. ISOTHERMAL AMPLIFICATION MARKET, BY REGION 6.5.1.1. NORTH AMERICA ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.5.1.2. EUROPE ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.5.1.3. ASIA ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.5.1.4. MIDDLE EAST & AFRICA ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.6. OTHER TECHNOLOGIES 6.6.1. OTHER TECHNOLOGIES MARKET, BY REGION 6.6.1.1. NORTH AMERICA OTHER TECHNOLOGIES MARKET, BY COUNTRY 6.6.1.2. EUROPE OTHER TECHNOLOGIES MARKET, BY COUNTRY 6.6.1.3. ASIA OTHER TECHNOLOGIES MARKET, BY COUNTRY 6.6.1.4. MIDDLE EAST & AFRICA OTHER TECHNOLOGIES MARKET, BY COUNTRY TABLE 90. MIDDLE EAST & AFRICA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF TABLES TABLE 01. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 02. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 03. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 04. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($MILLION) TABLE 07. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 08. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($MILLION) TABLE 09. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 11. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 12. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 13. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 14. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 15. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 16. UK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 17. UK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 18. UK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 19. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 20. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 21. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 22. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 23. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 24. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 25. REST OF EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 26. REST OF EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 27. REST OF EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 28. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 29. INFECTIOUS DISEASE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 30. NORTH AMERICA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. EUROPE INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. ASIA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. MIDDLE EAST & AFRICA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. ONCOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 35. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. EUROPE ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. ASIA ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. MIDDLE EAST & AFRICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. HEMATOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 40. NORTH AMERICA HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. EUROPE HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. ASIA HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. MIDDLE EAST & AFRICA HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. OTHER APPLICATIONS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 45. NORTH AMERICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. EUROPE OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. ASIA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. MIDDLE EAST & AFRICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 49. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 50. HOSPITALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 51. NORTH AMERICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. EUROPE HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. ASIA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 54. MIDDLE EAST & AFRICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. CLINICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 56. NORTH AMERICA CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. EUROPE CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. ASIA CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 59. MIDDLE EAST & AFRICA CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. OTHER END USERS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 61. NORTH AMERICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. EUROPE OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. ASIA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. MIDDLE EAST & AFRICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 66. PCR MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 67. NORTH AMERICA PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. EUROPE PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 69. ASIA PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 70. MIDDLE EAST & AFRICA PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 71. IN SITU HYBRIDIZATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 72. NORTH AMERICA IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 73. EUROPE IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 74. ASIA IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 75. MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 76. SEQUENCING MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 77. NORTH AMERICA SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 78. EUROPE SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 79. ASIA SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 80. MIDDLE EAST & AFRICA SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 81. ISOTHERMAL AMPLIFICATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 82. NORTH AMERICA ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 83. EUROPE ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 84. ASIA ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 85. MIDDLE EAST & AFRICA ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 86. OTHER TECHNOLOGIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 87. NORTH AMERICA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 88. EUROPE OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 89. ASIA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 90. MIDDLE EAST & AFRICA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF FIGURES CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET 3.1. OVERVIEW 3.2. EUROPE 3.2.1. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.2. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.3. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY 3.2.4.1. GERMANY 3.2.4.1.1. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.1.2. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.1.3. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.2. FRANCE 3.2.4.2.1. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.2.2. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.2.3. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.3. UK 3.2.4.3.1. UK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.3.2. UK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.3.3. UK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.4. ITALY 3.2.4.4.1. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.4.2. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.4.3. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.5. SPAIN 3.2.4.5.1. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.5.2. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.5.3. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 3.2.4.6. REST OF EUROPE 3.2.4.6.1. REST OF EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 3.2.4.6.2. REST OF EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 3.2.4.6.3. REST OF EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY CHAPTER 4: GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 4.1. OVERVIEW 4.2. INFECTIOUS DISEASE 4.2.1. INFECTIOUS DISEASE MARKET, BY REGION 4.2.1.1. NORTH AMERICA INFECTIOUS DISEASE MARKET, BY COUNTRY 4.2.1.2. EUROPE INFECTIOUS DISEASE MARKET, BY COUNTRY 4.2.1.3. ASIA INFECTIOUS DISEASE MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA INFECTIOUS DISEASE MARKET, BY COUNTRY 4.3. ONCOLOGY 4.3.1. ONCOLOGY MARKET, BY REGION 4.3.1.1. NORTH AMERICA ONCOLOGY MARKET, BY COUNTRY 4.3.1.2. EUROPE ONCOLOGY MARKET, BY COUNTRY 4.3.1.3. ASIA ONCOLOGY MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA ONCOLOGY MARKET, BY COUNTRY 4.4. HEMATOLOGY 4.4.1. HEMATOLOGY MARKET, BY REGION 4.4.1.1. NORTH AMERICA HEMATOLOGY MARKET, BY COUNTRY 4.4.1.2. EUROPE HEMATOLOGY MARKET, BY COUNTRY 4.4.1.3. ASIA HEMATOLOGY MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA HEMATOLOGY MARKET, BY COUNTRY 4.5. OTHER APPLICATIONS 4.5.1. OTHER APPLICATIONS MARKET, BY REGION 4.5.1.1. NORTH AMERICA OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.2. EUROPE OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.3. ASIA OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA OTHER APPLICATIONS MARKET, BY COUNTRY CHAPTER 5: GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER 5.1. OVERVIEW 5.2. HOSPITALS 5.2.1. HOSPITALS MARKET, BY REGION 5.2.1.1. NORTH AMERICA HOSPITALS MARKET, BY COUNTRY 5.2.1.2. EUROPE HOSPITALS MARKET, BY COUNTRY 5.2.1.3. ASIA HOSPITALS MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA HOSPITALS MARKET, BY COUNTRY 5.3. CLINICS 5.3.1. CLINICS MARKET, BY REGION 5.3.1.1. NORTH AMERICA CLINICS MARKET, BY COUNTRY 5.3.1.2. EUROPE CLINICS MARKET, BY COUNTRY 5.3.1.3. ASIA CLINICS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA CLINICS MARKET, BY COUNTRY 5.4. OTHER END USERS 5.4.1. OTHER END USERS MARKET, BY REGION 5.4.1.1. NORTH AMERICA OTHER END USERS MARKET, BY COUNTRY 5.4.1.2. EUROPE OTHER END USERS MARKET, BY COUNTRY 5.4.1.3. ASIA OTHER END USERS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA OTHER END USERS MARKET, BY COUNTRY CHAPTER 6: GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 6.1. OVERVIEW 6.2. PCR 6.2.1. PCR MARKET, BY REGION 6.2.1.1. NORTH AMERICA PCR MARKET, BY COUNTRY 6.2.1.2. EUROPE PCR MARKET, BY COUNTRY 6.2.1.3. ASIA PCR MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA PCR MARKET, BY COUNTRY 6.3. IN SITU HYBRIDIZATION 6.3.1. IN SITU HYBRIDIZATION MARKET, BY REGION 6.3.1.1. NORTH AMERICA IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.3.1.2. EUROPE IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.3.1.3. ASIA IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET, BY COUNTRY 6.4. SEQUENCING 6.4.1. SEQUENCING MARKET, BY REGION 6.4.1.1. NORTH AMERICA SEQUENCING MARKET, BY COUNTRY 6.4.1.2. EUROPE SEQUENCING MARKET, BY COUNTRY 6.4.1.3. ASIA SEQUENCING MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA SEQUENCING MARKET, BY COUNTRY 6.5. ISOTHERMAL AMPLIFICATION 6.5.1. ISOTHERMAL AMPLIFICATION MARKET, BY REGION 6.5.1.1. NORTH AMERICA ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.5.1.2. EUROPE ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.5.1.3. ASIA ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.5.1.4. MIDDLE EAST & AFRICA ISOTHERMAL AMPLIFICATION MARKET, BY COUNTRY 6.6. OTHER TECHNOLOGIES 6.6.1. OTHER TECHNOLOGIES MARKET, BY REGION 6.6.1.1. NORTH AMERICA OTHER TECHNOLOGIES MARKET, BY COUNTRY 6.6.1.2. EUROPE OTHER TECHNOLOGIES MARKET, BY COUNTRY 6.6.1.3. ASIA OTHER TECHNOLOGIES MARKET, BY COUNTRY 6.6.1.4. MIDDLE EAST & AFRICA OTHER TECHNOLOGIES MARKET, BY COUNTRY TABLE 01. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 02. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 03. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 04. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($MILLION) TABLE 07. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 08. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($MILLION) TABLE 09. EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 11. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 12. GERMANY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 13. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 14. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 15. FRANCE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 16. UK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 17. UK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 18. UK POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 19. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 20. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 21. ITALY POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 22. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 23. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 24. SPAIN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 25. REST OF EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 26. REST OF EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 27. REST OF EUROPE POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 28. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY APPLICATION , 2023-2030, ($ MILLION) TABLE 29. INFECTIOUS DISEASE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 30. NORTH AMERICA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. EUROPE INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. ASIA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. MIDDLE EAST & AFRICA INFECTIOUS DISEASE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. ONCOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 35. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. EUROPE ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. ASIA ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. MIDDLE EAST & AFRICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. HEMATOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 40. NORTH AMERICA HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. EUROPE HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. ASIA HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. MIDDLE EAST & AFRICA HEMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. OTHER APPLICATIONS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 45. NORTH AMERICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. EUROPE OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. ASIA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. MIDDLE EAST & AFRICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 49. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 50. HOSPITALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 51. NORTH AMERICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. EUROPE HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. ASIA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 54. MIDDLE EAST & AFRICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. CLINICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 56. NORTH AMERICA CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. EUROPE CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. ASIA CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 59. MIDDLE EAST & AFRICA CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. OTHER END USERS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 61. NORTH AMERICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. EUROPE OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. ASIA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. MIDDLE EAST & AFRICA OTHER END USERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET VALUE, BY TECHNOLOGY, 2023-2030, ($ MILLION) TABLE 66. PCR MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 67. NORTH AMERICA PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. EUROPE PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 69. ASIA PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 70. MIDDLE EAST & AFRICA PCR MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 71. IN SITU HYBRIDIZATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 72. NORTH AMERICA IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 73. EUROPE IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 74. ASIA IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 75. MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 76. SEQUENCING MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 77. NORTH AMERICA SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 78. EUROPE SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 79. ASIA SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 80. MIDDLE EAST & AFRICA SEQUENCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 81. ISOTHERMAL AMPLIFICATION MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 82. NORTH AMERICA ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 83. EUROPE ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 84. ASIA ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 85. MIDDLE EAST & AFRICA ISOTHERMAL AMPLIFICATION MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 86. OTHER TECHNOLOGIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 87. NORTH AMERICA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 88. EUROPE OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 89. ASIA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 90. MIDDLE EAST & AFRICA OTHER TECHNOLOGIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)